T1	Participants 43 124	female patients undergoing curative adjuvant irradiation following breast cancer]
T2	Participants 574 669	50 patients submitted to curative adjuvant irradiation following surgery for mammary carcinoma.
T3	Participants 724 801	patients with irradiations of the thoracic wall and the regional lymph nodes.
